What is the story about?
Shares of medtech firm Poly Medicure Ltd
on Monday (May 25) tanked 5% after it reported a 27.8% year-on-year decline in net profit for the fourth quarter of FY26 at ₹66.3 crore, compared with ₹91.8 crore in the corresponding quarter last year.
Revenue grew 21.3% year-on-year to ₹534.5 crore from ₹440.8 crore a year ago. EBITDA declined 7.8% to ₹110.3 crore in the January-March quarter from ₹120 crore in the year-ago period. EBITDA margin stood at 20.6% compared with 27.1% last year.
The company’s board recommended a dividend of ₹3.5 per equity share of face value ₹5 each for FY26, subject to shareholders’ approval. Shares of Poly Medicure Ltd ended at ₹1,518.00, down by ₹80.75, or 5.05%, on the BSE.
Revenue grew 21.3% year-on-year to ₹534.5 crore from ₹440.8 crore a year ago. EBITDA declined 7.8% to ₹110.3 crore in the January-March quarter from ₹120 crore in the year-ago period. EBITDA margin stood at 20.6% compared with 27.1% last year.
The company’s board recommended a dividend of ₹3.5 per equity share of face value ₹5 each for FY26, subject to shareholders’ approval. Shares of Poly Medicure Ltd ended at ₹1,518.00, down by ₹80.75, or 5.05%, on the BSE.

/images/ppid_59c68470-image-177953506176496960.webp)

/images/ppid_59c68470-image-177945255251348163.webp)
/images/ppid_59c68470-image-177946252626287255.webp)
/images/ppid_59c68470-image-177946506036732454.webp)
/images/ppid_59c68470-image-177946503307212526.webp)
/images/ppid_59c68470-image-177947252452132942.webp)
/images/ppid_59c68470-image-177944257043991387.webp)
/images/ppid_59c68470-image-17795275300255982.webp)

